The 91st Edition HDA Factbook (2020–2021) provides comprehensive distribution performance metrics that highlight growth and trends in the pharmaceutical industry.
NON - MEMBER PRICE: $0.00 | MEMBER PRICE: $0.00
(Webinar held: October 27, 2020) Join HDA and The Hill for a virtual conversation between policymakers, health officials and healthcare stakeholders on ensuring resilience in the pharmaceutical supply...
Developed in collaboration with Deloitte Consulting LLP, this report examines the role that the supply chain played in delivering medicines safely and efficiently to patients during the unprecedented early...
(Webinar held: October 26, 2020) COVID-19 continues to have a far-reaching effect on the nation's economy, including the pharmaceutical sector.
These guidelines educate trading partners across the healthcare supply chain in the processes used for the negotiation and administration of contracts, as well as the submission, validation and reconciliation...
PRICE : $0.00 - $75.00
Add to Cart
This white paper provides a brief overview of the pharmaceutical supply chain, product supply issues and current processes that can result in product shortages.
PRICE : $0.00 - $0.00
Add to Cart
Developed by HDMA’s Returns Task Force, this summary reports the volume and average dollar value of returned prescription and over-the-counter products processed by reverse logistics providers.
PRICE : $0.00 - $495.00
Add to Cart
Developed by the HDMA Returns Task Force, this article identifies ways to reduce unsalable returns and reduce supply chain waste.
Download PDF
Developed by HDMA’s Returns Task Force, these voluntary guidelines provide insights into industry recall and withdrawal practices, as well as strategies for manufacturers and distributors to effectively...
PRICE : $0.00 - $495.00
Add to Cart
Trading partners may use this sample returned goods debit memo template to clearly convey the pertinent information about returned pharmaceuticals and facilitate the credit reconciliation process.
PRICE : $0.00 - $0.00
Add to Cart
This report focuses on the opportunities to improve communications between trading partners as a branded pharmaceutical product nears the end of its patent protection to better manage inventory and reduce...
PRICE : $0.00 - $0.00
Add to Cart
Developed by HDMA’s Returns Task Force, this report addresses key issues and recommends process improvements for returned or unsalable healthcare products.
PRICE : $0.00 - $495.00
Add to Cart
These recommendations suggest practices that a pharmaceutical entity could employ to identify and help minimize the risks associated with storing pharmaceutical products.
PRICE : $0.00 - $495.00
Add to Cart
Violent attacks are increasing in the last mile for pharmaceutical supply chain distribution. These suggested guidelines offer companies seeking to strengthen their in-transit security program a directed...
PRICE : $0.00 - $495.00
Add to Cart